The significant compound responses noted in the medium-dose and high-dose OBS groups were accounted for by the significant histologic responses ; in contrast , all @ groups ( including the placebo group ) had large symptom responses , and there was no significant difference in the percentage of subjects with a symptom response in either OBS group compared with the placebo group ( P @ ) .